CEDAR researcher: Joshua Moreau, Ph.D.
Moreau’s lab has found promising research on a type of immune cell, the memory B cell, that could act as a therapeutic target for cancer.
Moreau’s lab has found promising research on a type of immune cell, the memory B cell, that could act as a therapeutic target for cancer.
Franca is a core faculty member in the Knight Cancer Precision Biofabrication Hub, recreating environments on-a-chip to study epithelial cancer development.
Schutt Ibsen uses ultrasound waves to control the behavior of cells deep within the tissues she engineers, allowing for precise genetic changes.
Brian Park, M.D., M.P.H., discusses using place-based health to guide OHSU’s efforts in creating a healthier, more equitable future for all.
Stephen Back, M.D., Ph.D., credits donor funding for giving him and his team the freedom to make significant findings.
David Brockman came to OHSU for CAR T-cell treatment to treat a rare type of lymphoma. His positive experience inspired him to give on Give Day 2023.